4Mishkin J D,Saxonhouse S J,Woo G W,et al. Appropriate evaluation and treatment of heart failure patients after implantable cardiovert- er-defibrillator discharge: time to go beyond the initial shock.J Am Coil Cardiol,2009,54 : 1993-2000.
5Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/ HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiplofy/American Heart Association Task Force on Prac- tice Guidelines developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons[ J]. J Am Coil Cardiol,2008,51 (21) :el.
6Kuck KH, Cappato R, Siebels J, et al. Randomized compar- ison of antiarrhythmic drug therapy with implantable defib-rillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH) [ J ]. Circulation, 2000,102 (7) :748.
8Stuber T, Eigenmann C, Delacretaz Z, et al. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients [ J ]. Pacing Clin Electrophysio1,2005,28 (7) :702.
9Brigadeau F,Kouakam C, Klug D, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators [ J ]. Eur Heart J, 2006,27 ( 6 ) : 700.
10Green UB, Garg A, A1-Kandari F, et al. Successful implan- tation of cardiac defibrillators without induction of ventricu- lar fibrillation using upper limit of vulnerability testing[ J ]. J Interv Card Electrophysiol,2003,8( 1 ) :71.
